28 Nov 2016
When it comes to value frameworks, one thing is certain, they’re here to stay.
The balance of power behind the prescribing decision is changing: payers are ever more in charge. That means that insight into how payers make decisions - how they evaluate drugs, one against another - will be crucial to any successful drug launch.
How it works
RxScorecard™ objectively shows how your payer customers will see your product and your competitors'. Access scores for competitive drugs on all key efficacy, safety, adherence, and economic metrics most meaningful for payers, and gain powerful insight on how you can effectively differentiate your product and maximize your drugs market potential.
RxScorecard helps you to:
View the relative value of marketed and pipeline agents by therapeutic area and patient population, all from a payer’s perspective
Access scores for competitive drugs on up to 36 efficacy, safety, adherence and economic metrics most meaningful for payers
All data points are supported by embedded links to the most up-to-date evidence available
Create different data scenarios & add proprietary data to see where you can improve your drug’s value proposition. Perform real-time war gaming.
23 Nov 2016
See how the value of drugs differentiate therapies by sub-population. Find out where the disproportionate value of your drug lies alongside competitors. Uncover demonstrable differentiated value when entering a crowded market. Discover the power of RxScorecard™.
11 Oct 2016
RxScorecard™ is the first and only tool to assess the value of marketed and pipeline drugs – objectively, systematically, transparently – from the payer’s point of view.
Beth specializes in
+20 year(s) experience
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: